Biodistribution and catabolism of 18F-labeled neurotensin(8-13) analogs

Nuclear Medicine and Biology

Volumn 29, Issue 1, 2002, Pages 61-72

  Bergmann, Ralf ^a   Scheunemann, Matthias ^a   Heichert, Christoph ^a   Mäding, Peter ^a   Wittrisch, Holm ^a   Kretzschmar, Marion ^a   Rodig, Heike ^a   Tourwé, Dirk ^b   Iterbeke, Koen ^b   Chavatte, Kris ^b   Zips, Daniel ^d   Reubi, Jean Claude ^c   Johannsen, Bernd ^a  

^a INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY OF BERN   (Switzerland)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

F 18; Neurotensin analogs; Positron emission tomography; Receptor binding; Tumor

Indexed keywords

4 FLUOROBENZOYL NEUROTENSIN[8-13] F 18; ENZYME INHIBITOR; NEUROTENSIN DERIVATIVE; NEUROTENSIN RECEPTOR; PEPTIDASE; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL LINE; CELL STRAIN HT29; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG SPECIFICITY; DRUG STABILITY; DRUG UPTAKE; FEMALE; FLUORINATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INTERNALIZATION; ISOTOPE LABELING; LIGAND BINDING; MALE; MOUSE; MUSCLE; NONHUMAN; PEPTIDE SYNTHESIS; PLASMA CLEARANCE; POSITRON EMISSION TOMOGRAPHY; PROTEIN DEGRADATION; RADIOCHEMISTRY; RAT; RECEPTOR AFFINITY; SPECIES DIFFERENCE; TUMOR; TUMOR DIAGNOSIS; TUMOR SCINTISCANNING;

ANIMALS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; CALCIUM; FLUORINE RADIOISOTOPES; HALF-LIFE; HT29 CELLS; HUMANS; METABOLIC CLEARANCE RATE; MICE; NEUROTENSIN; PEPTIDE FRAGMENTS; RADIOCHEMISTRY; RATS; RATS, WISTAR; RECEPTORS, NEUROTENSIN; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION;

EID: 0036148310     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(01)00284-0     Document Type: Article

References (51)

1. + following the IEC standard
2. Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1
3. Quantitative evaluation of the effects of cotransplantation of heavily irradiated human tumor cells and of different immunosuppressive measures on the xenotransplanability of a human squamous cell carcinoma into athymic nude mice
4. 18F-labelled neutrotensin(8-13) analogs for positron emission tomography (PET), Pharmacological and biochemical characterisation
5. Pharmacological investigation of metabolically stabilized peptides labelled with technetium-99m
6. New hydroxamate inhibitors of neurotensin-degrading enzymes. Synthesis and enzyme active-site recognition
7. Rhenium (Re) and technetium oxocomplexes of neurotensin(8-13)
8. Labelling and evaluation of new stabilised neurotensin (8-13) analogues for single photon emission tomography (SPET)
9. 12-]NT(10-13): Radiosynthesis and characterisation
10. 201Tl(III)DTPA-neurotensin(8-13)
11. Degradation of neurotensin by rat brain synaptic membranes: Involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases
12. Neurotensin metabolism in various tissues of central and peripheral origin: Ubiquitous involvement of a novel neurotensin degrading metalloendopeptidase
13. Immunohistochemical localization of endopeptidase 24.15 in rat trachea, lung tissue, and alveolar macrophages
14. 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts
15. Gut peptide receptor expression in human pancreatic cancers
16. An efficient synthesis of optically active α-(butyloxycarbonylamino)-aldehydes from α-amino acids
17. Preparation of radiolabelled human C-peptide by conjugation with, N-succinimidyl-4-[, 18F]fluorobenzoate
18. 1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: Synthesis, radiolabeling, in vitro validation and biodistribution in mice
19. 18F-labeled RGD-peptides
20. 88/90Y]yttrium
21. Receptor targeting for tumor localisation and therapy with radiopeptides
22. 18F]fluorobenzoyl octreotide and biodistribution in tumor-bearing Lewis rats
23. Optimization of a neurotensin(8-13) analogue for radioiodination
24. Hydrolysis of peptide hormones by endothelin-converting enzyme-1
25. Pharmacology and biochemistry of neurotensin receptors
26. Characterization of neutral endopeptidase 24.11 in dog glomeruli
27. Renal handling of iodobenzoates in rats
28. 99mTc-labeled small peptides as diagnostic radiopharmaceuticals
29. Reduced peptide bond pseudopeptide analogues of neurotensin: Binding and biological activities, and in vitro metabolic stability
30. Radiolabeled peptides and other ligands for receptors overexpressed in tumor cells for imaging neoplasms
31. Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes
32. Neuropeptide receptors in health and disease: The molecular basis for in vivo imaging
33. Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy
34. Neurotensin receptors: A new marker for human ductal pancreatic adenocarcinoma
35. Receptor autoradiograpic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: Where are they located?
36. Regulatory peptide receptors in human hepatocellular carcinomas
37. Neurotensin receptors in human neoplasms: High incidence in Ewing's sarcomas
38. 2NH] pseudopeptide analogues of a highly potent somatostatin octapeptide
39. Fluorine-18 labelling of neurotensin analogues for the development of tumor imaging agents
40. Catabolism of neurotensin: Implications for the design of radiolabeling strategies of peptides
41. 18F]labelled peptides using a solid phase methodology
42. 18F]-labelled linear peptides
43. 99mTc-labeled peptides
44. Neurotensin: Peptide for the next millenium
45. 7]-α-MSH, an α-melanocyte stimulating hormone analogue
46. Neurotensin and neurotensin receptors
47. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease
48. A comparative study of N.C.A. fluorine-18 labeling of proteins via acylation and photochemical conjugation
49. 86Y-DTPA-octreotide
50. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice